Conspectus
Signaling lipids, such as the
endocannabinoids, play an important
role in the brain. They regulate synaptic transmission and control
various neurophysiological processes, including pain sensation, appetite,
memory formation, stress, and anxiety. Unlike classical neurotransmitters,
lipid messengers are produced on demand and degraded by metabolic
enzymes to control their lifespan and signaling actions. Chemical
biology approaches have become one of the main driving forces to study
and unravel the physiological role of lipid messengers in the brain.
Here, we review how the development and use of chemical probes has
allowed one to study endocannabinoid signaling by (i) inhibiting the
biosynthetic and metabolic enzymes; (ii) visualizing the activity
of these enzymes; and (iii) controlling the release and transport
of the endocannabinoids. Activity-based probes were instrumental to
guide the discovery of highly selective and in vivo active inhibitors
of the biosynthetic (DAGL, NAPE-PLD) and metabolic (MAGL, FAAH) enzymes
of endocannabinoids. These inhibitors allowed one to study the role
of these enzymes in animal models of disease. For instance, the DAGL–MAGL
axis was shown to control neuroinflammation and the NAPE-PLD–FAAH
axis to regulate emotional behavior. Activity-based protein profiling
and chemical proteomics were essential to guide the drug discovery
and development of compounds targeting MAGL and FAAH, such as ABX-1431
(Lu AG06466) and PF-04457845, respectively. These experimental drugs
are now in clinical trials for multiple indications, including multiple
sclerosis and post-traumatic stress disorders. Activity-based probes
have also been used to visualize the activity of these lipid metabolizing
enzymes with high spatial resolution in brain slices, thereby showing
the cell type-specific activity of these lipid metabolizing enzymes.
The transport, release, and uptake of signaling lipids themselves
cannot, however, be captured by activity-based probes in a spatiotemporal
controlled manner. Therefore, bio-orthogonal lipids equipped with
photoreactive, photoswitchable groups or photocages have been developed.
These chemical probes were employed to investigate the protein interaction
partners of the endocannabinoids, such as putative membrane transporters,
as well as to study the functional cellular responses within milliseconds
upon irradiation. Finally, genetically encoded sensors have recently
been developed to monitor the real-time release of endocannabinoids
with high spatiotemporal resolution in cultured neurons, acute brain
slices, and in vivo mouse models. It is anticipated that the combination
of chemical probes, highly selective inhibitors, and sensors with
advanced (super resolution) imaging modalities, such as PharmacoSTORM
and correlative light-electron microscopy, will uncover the fundamental
basis of lipid signaling at nanoscale resolution in the brain. Furthermore,
chemical biology approaches enable the translation of these fundamental
discoveries into clinical solutions for brain dis...